Overview
- Spain’s GECP reports one in 20 diagnoses now occur before age 50, with 2024 deaths reaching 23,239 and female mortality rising 7% year over year, according to INE data.
- More than half of patients are still diagnosed at stages III–IV, five‑year survival remains near 30%, and gains over the past decade reflect advances in therapy.
- Andalusian oncologists say up to one in five new cases occur in people who never smoked, linking risk to air pollution, radon and occupational exposures, alongside EGFR, ALK and ROS1 alterations.
- Experts call for low‑dose CT programs that have cut mortality by up to about 20% in studies, with Argentina’s national consensus outlining annual screening criteria for high‑risk adults.
- Access to tumor genomic testing in Spain now exceeds 80%, yet GECP warns lung cancer receives only 4% of public cancer‑research funding and urges stronger, more equitable investment.